The art of targeting cancer therapies: an interview with Professor Paul Workman
15 September 2008
Malini Guha
Please Login to read the full article.
15 September 2008
Malini Guha
malini.guha@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Comparative efficacy should have a "formal role in drug licensing"
- BMS and Sanofi mentioned in $1bn deal speculation over Biocon's oral insulin
- Roche expands hepatitis C deal with Merck after Victrelis' EU nod
- Pharmacyclics raises $57M to advance tyrosine kinase inhibitor for blood cancers
